BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34223961)

  • 21. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
    Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
    Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution pancreatic computed tomography for assessing pancreatic ductal adenocarcinoma resectability: a multicenter prospective study.
    Lee DH; Ha HI; Jang JY; Lee JW; Choi JY; Bang S; Lee CH; Kim WB; Lee SS; Kim SC; Kang BK; Lee JM
    Eur Radiol; 2023 Sep; 33(9):5965-5975. PubMed ID: 36988715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting pancreatic ductal adenocarcinoma using artificial intelligence analysis of pre-diagnostic computed tomography images.
    Qureshi TA; Gaddam S; Wachsman AM; Wang L; Azab L; Asadpour V; Chen W; Xie Y; Wu B; Pandol SJ; Li D
    Cancer Biomark; 2022; 33(2):211-217. PubMed ID: 35213359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
    Cheng SH; Cheng YJ; Jin ZY; Xue HD
    Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Automated Quantitative Analysis of CT Perfusion to Classify Vascular Phenotypes of Pancreatic Ductal Adenocarcinoma.
    Perik T; Alves N; Hermans JJ; Huisman H
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
    Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
    Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.
    Yeh R; Dercle L; Garg I; Wang ZJ; Hough DM; Goenka AH
    Abdom Radiol (NY); 2018 Feb; 43(2):415-434. PubMed ID: 29143875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CT-perfusion in peripheral arterial disease - Correlation with angiographic and hemodynamic parameters.
    Sah BR; Veit-Haibach P; Strobel K; Banyai M; Huellner MW
    PLoS One; 2019; 14(9):e0223066. PubMed ID: 31560706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
    Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
    Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
    Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
    J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
    Baliyan V; Kordbacheh H; Parakh A; Kambadakone A
    Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DeepPrognosis: Preoperative prediction of pancreatic cancer survival and surgical margin via comprehensive understanding of dynamic contrast-enhanced CT imaging and tumor-vascular contact parsing.
    Yao J; Shi Y; Cao K; Lu L; Lu J; Song Q; Jin G; Xiao J; Hou Y; Zhang L
    Med Image Anal; 2021 Oct; 73():102150. PubMed ID: 34303891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative perfusion analysis of transabdominal contrast-enhanced ultrasonography of pancreatic masses and carcinomas.
    Kersting S; Konopke R; Kersting F; Volk A; Distler M; Bergert H; Saeger HD; Grützmann R; Bunk A
    Gastroenterology; 2009 Dec; 137(6):1903-11. PubMed ID: 19715694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of response using FDG-PET/CT and diffusion weighted MRI after radiochemotherapy of pancreatic cancer: a non-randomized, monocentric phase II clinical trial-PaCa-DD-041 (Eudra-CT 2009-011968-11).
    Zimmermann C; Distler M; Jentsch C; Blum S; Folprecht G; Zöphel K; Polster H; Troost EGC; Abolmaali N; Weitz J; Baumann M; Saeger HD; Grützmann R
    Strahlenther Onkol; 2021 Jan; 197(1):19-26. PubMed ID: 32638040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic perfusion CT - A promising tool to diagnose pancreatic ductal adenocarcinoma.
    Zaborienė I; Barauskas G; Gulbinas A; Ignatavičius P; Lukoševičius S; Žvinienė K
    Open Med (Wars); 2021; 16(1):284-292. PubMed ID: 33681467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma.
    Kambadakone AR; Zaheer A; Le O; Bhosale P; Meier J; Guimaraes AR; Shah Z; Hough DM; Mannelli L; Soloff E; Friedman A; Tamm E
    Abdom Radiol (NY); 2018 Feb; 43(2):245-252. PubMed ID: 29277858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic CT perfusion: quantitative meta-analysis of disease discrimination, protocol development, and effect of CT parameters.
    Skornitzke S; Vats N; Mayer P; Kauczor HU; Stiller W
    Insights Imaging; 2023 Jul; 14(1):132. PubMed ID: 37477754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation.
    Schima W; Böhm G; Rösch CS; Klaus A; Függer R; Kopf H
    Cancer Imaging; 2020 Jul; 20(1):52. PubMed ID: 32703312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.